132 related articles for article (PubMed ID: 36629160)
1.
Wang YZ; Qian YC; Yang WJ; Ye LH; Guo GD; Lv W; Huan MX; Feng XY; Wang K; Yang Z; Gao Y; Li L; Chen YL
Asian J Androl; 2023; 25(2):152-157. PubMed ID: 36629160
[TBL] [Abstract][Full Text] [Related]
2. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.
Ordóñez-Navadijo Á; Fuertes-Yebra E; Acosta-Iborra B; Balsa E; Elorza A; Aragonés J; Landazuri MO
Oncogene; 2016 Feb; 35(5):587-94. PubMed ID: 25915846
[TBL] [Abstract][Full Text] [Related]
3. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
4. Hydroxylation-Dependent Interaction of Substrates to the Von Hippel-Lindau Tumor Suppressor Protein (VHL).
Heir P; Ohh M
Methods Mol Biol; 2016; 1458():87-94. PubMed ID: 27581016
[TBL] [Abstract][Full Text] [Related]
5. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.
Li Y; Zhang D; Wang X; Yao X; Ye C; Zhang S; Wang H; Chang C; Xia H; Wang YC; Fang J; Yan J; Ying H
Sci Rep; 2015 Jul; 5():12495. PubMed ID: 26205124
[TBL] [Abstract][Full Text] [Related]
8. EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate.
Pascal LE; Ai J; Rigatti LH; Lipton AK; Xiao W; Gnarra JR; Wang Z
Angiogenesis; 2011 Sep; 14(3):331-43. PubMed ID: 21638067
[TBL] [Abstract][Full Text] [Related]
9. The involvement of hypoxia-inducible factor 1α (HIF1α)-stabilising factors in steroidogenic acute regulatory (STAR) protein-dependent steroidogenesis in murine KK1 granulosa cells in vitro.
Gysin T; Kowalewski MP
Reprod Fertil Dev; 2021 Dec; 33(18):865-880. PubMed ID: 34871543
[TBL] [Abstract][Full Text] [Related]
10. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway.
Li CH; Liao PL; Yang YT; Huang SH; Lin CH; Cheng YW; Kang JJ
Arch Toxicol; 2014 Mar; 88(3):659-71. PubMed ID: 24292262
[TBL] [Abstract][Full Text] [Related]
11. Radiation promotes malignant progression of glioma cells through HIF-1alpha stabilization.
Kim YH; Yoo KC; Cui YH; Uddin N; Lim EJ; Kim MJ; Nam SY; Kim IG; Suh Y; Lee SJ
Cancer Lett; 2014 Nov; 354(1):132-41. PubMed ID: 25109450
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA GEHT1 promoted the proliferation of ovarian cancer cells via modulating the protein stability of HIF1α.
Liu D; Li H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988076
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.
Liu N; Xia WY; Liu SS; Chen HY; Sun L; Liu MY; Li LF; Lu HM; Fu YJ; Wang P; Wu H; Gao JX
Sci Rep; 2016 Feb; 6():20489. PubMed ID: 26841847
[TBL] [Abstract][Full Text] [Related]
14. [CRISPR/Cas9-editing-based modeling of hypoxia in renal cancer cells].
Zhigalova NA; Zhenilo SV; Artemov AV; Prokhortchouk EB
Mol Biol (Mosk); 2017; 51(5):836-840. PubMed ID: 29116071
[TBL] [Abstract][Full Text] [Related]
15. Increased hypoxia-inducible factor-1α in striated muscle of tumor-bearing mice.
Devine RD; Bicer S; Reiser PJ; Wold LE
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1154-H1162. PubMed ID: 28341633
[TBL] [Abstract][Full Text] [Related]
16. von Hippel-Lindau β-domain-luciferase fusion protein as a bioluminescent hydroxyproline sensor for a hypoxia-inducible factor prolyl hydroxylase assay.
Hong S; Yum S; Ha NC; Jung Y
Anal Biochem; 2010 Dec; 407(2):220-5. PubMed ID: 20705044
[TBL] [Abstract][Full Text] [Related]
17. Sprouty2 Protein Regulates Hypoxia-inducible Factor-α (HIFα) Protein Levels and Transcription of HIFα-responsive Genes.
Hicks KC; Patel TB
J Biol Chem; 2016 Aug; 291(32):16787-801. PubMed ID: 27281823
[TBL] [Abstract][Full Text] [Related]
18. iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation.
Zhao D; Zheng S; Wang X; Liu H; Zhao K; Li L; Hu Y
Oncogene; 2022 Mar; 41(13):1944-1958. PubMed ID: 35169254
[TBL] [Abstract][Full Text] [Related]
19. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
[TBL] [Abstract][Full Text] [Related]
20. Methyltransferase SMYD3 impairs hypoxia tolerance by augmenting hypoxia signaling independent of its enzymatic activity.
Wang Z; Chen X; Fan S; Zhu C; Deng H; Tang J; Sun X; Jia S; Liao Q; Xiao W; Liu X
J Biol Chem; 2022 Dec; 298(12):102633. PubMed ID: 36273580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
